Insiders Zymeworks Inc.

Equities

ZYME

US98985Y1082

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-17 pm EDT			5-day change	1st Jan Change
8.54 ^USD	-5.53%		-4.79%	-17.81%

Jun. 17	Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy	MT
Jun. 17	Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers	DJ

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zymeworks Inc. Removes Dr. Christopher Astle from the Positions of Senior Vice President	Apr. 04	CI
Zymeworks Inc. Announces the Composition of the Committees	Mar. 28	CI
Zymeworks Inc. Announces Appointment of Neil Gallagher to Its Board of Directors and as Member of the Research and Development Committee, Effective April 2, 2024	Mar. 28	CI
Zymeworks Inc. Appoints Scott Platshon as Director	Feb. 22	CI
Zymeworks Announces Appointment of Dr. Alessandra Cesano to Its Board of Directors	Feb. 08	CI
Zymeworks Insider Sold Shares Worth $257,845, According to a Recent SEC Filing	Jan. 09	MT
Zymeworks Appoints Jeffrey Smith as Chief Medical Officer; Cash Runway Extended	Jan. 04	MT
Zymeworks Inc Announces Additional Leadership Appointments	Jan. 04	CI
Zymeworks Inc. Announces Changes to its Board	Dec. 08	CI
Zymeworks Inc Announces Resignation of Lota Zoth as Member of the Board of Directors	23-10-16	CI
Zymeworks Inc. Announces Board Changes, Effective June 30, 2023	23-06-29	CI
Zymeworks Inc. Announces Executive Changes	23-05-18	CI
Zymeworks Inc. Announces Appointment of Derek J. Miller to Its Board of Directors	23-04-10	CI
Zymeworks Updates on Cash Resources; Chief Medical Officer to Depart Amid Internal Reorganization	23-01-04	MT
Zymeworks Inc. Removes Neil Josephson from the Position of Chief Medical Officer	23-01-04	CI
Zymeworks Inc. has Changed its Name to Zymeworks BC Inc	22-10-13	CI
Zymeworks Names COO Neil Klompas as President	22-08-05	MT
Zymeworks Inc. Appoints Mr. Neil Klompas as President	22-08-05	CI
Zymeworks Plans to Become a Delaware Corporation; Name, Brand, Ticker Symbol to Remain Unchanged	22-07-15	MT
Zymeworks Appoints Paul Moore Chief Scientific Officer	22-06-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Zymeworks Inc.

Equities

ZYME

US98985Y1082

Insiders

Filters